Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Lo Cascio

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
European Review for Medical and Pharmacological Sciences|March 27, 2014
Candidemia in intensive care unit: a nationwide prospective observational survey (GISIA-3 study) and review of the European literature from 2000 through 2013M T Montagna, G Lovero, E Borghi, et al.
ESMO Open|August 27, 2022
Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concernA Lasagna, F Bergami, D Lilleri, et al.
ESMO Open|April 15, 2022
Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort studyA Lasagna, F Bergami, D Lilleri, et al.
ESMO Open|January 1, 2022
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-upA Lasagna, D Lilleri, F Agustoni, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 6, 2014
European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in EuropeA M Tortorano, A Prigitano, M C Esposto, et al.
ESMO Open|September 20, 2021
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort studyA Lasagna, F Agustoni, E Percivalle, et al.
Journal of Global Antimicrobial Resistance|February 17, 2020
Prospective multicentre study on azole resistance in Aspergillus isolates from surveillance cultures in haematological patients in ItalyA Prigitano, M C Esposto, A Grancini, et al.
Infection|October 24, 2013
SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patientsM T Montagna, G Lovero, C Coretti, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 17, 2017
A prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint studyB Risslegger, T Zoran, M Lackner, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
European Review for Medical and Pharmacological Sciences|March 27, 2014
Candidemia in intensive care unit: a nationwide prospective observational survey (GISIA-3 study) and review of the European literature from 2000 through 2013M T Montagna, G Lovero, E Borghi, et al.
ESMO Open|August 27, 2022
Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concernA Lasagna, F Bergami, D Lilleri, et al.
ESMO Open|April 15, 2022
Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort studyA Lasagna, F Bergami, D Lilleri, et al.
ESMO Open|January 1, 2022
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-upA Lasagna, D Lilleri, F Agustoni, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 6, 2014
European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in EuropeA M Tortorano, A Prigitano, M C Esposto, et al.
ESMO Open|September 20, 2021
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort studyA Lasagna, F Agustoni, E Percivalle, et al.
Journal of Global Antimicrobial Resistance|February 17, 2020
Prospective multicentre study on azole resistance in Aspergillus isolates from surveillance cultures in haematological patients in ItalyA Prigitano, M C Esposto, A Grancini, et al.
Infection|October 24, 2013
SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patientsM T Montagna, G Lovero, C Coretti, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 17, 2017
A prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint studyB Risslegger, T Zoran, M Lackner, et al.
Pageof 4